Here are five things to know about the Asian orthobiologics market:
1. The market is expected to develop at a compound annual growth rate of 5.2 percent from 2013 to 2018.
2. The major factors driving the growth of the Asian orthopedic devices market is the increase in the middle class population, which now have higher disposable income and spending capabilities for orthopedic conditions.
3. The aging population is the main demographic of the orthobiologics market.
4. The major markets in this region include China, Japan and India. Japan is the largest market for orthopedic products and orthobiologics, and in 2014, it accounts for 40 percent of the Asian market.
5. According to a new report from Transparency Market Research, the Asia-Pacific market is expected to have the fastest growth rate through 2019 globally.
More articles on devices:
Zimmer, Medtronic, K2M & more — 17 key notes
Medtronic ditches foreign subsidiary cash, will use $16B external financing for Covidien deal
Inc. names Genesys Spine one of the fastest-growing private U.S. companies
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
